Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Date of refusal: 21/11/2025, Status: Refused

Human medicines European public assessment report (EPAR): Byfavo, remimazolam, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Talvey, talquetamab, Date of authorisation: 21/08/2023, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Livogiva, teriparatide, Date of authorisation: 27/08/2020, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Memantine Mylan, memantine, Date of authorisation: 21/04/2013, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Fingolimod Mylan, fingolimod, Date of authorisation: 18/08/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 29, Status: Authorised

Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG)

Eighth European Medicines Agency (EMA) and Medicines for Europe bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 15 December 2025, 15:00 (CET) to 15 December 2025, 17:00 (CET)

Human medicines European public assessment report (EPAR): Rolcya, denosumab, Date of authorisation: 17/07/2025, Revision: 2, Status: Authorised